Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Pfizer Hellas AE

Femme et Homme Max 99 ans
Pfizer Hellas AE MAJ Il y a 4 ans

A SIXTEEN-WEEK, MULTI-CENTER, OPEN-LABEL STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF SWITCHING FROM QUETIAPINE TO ZIPRASIDONE IN SUBJECTS DIAGNOSED WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER The primary objective of this study is to evaluate change in weight as a result of switching to ziprasidone, in subjects who have failed to achieve a satisfactory clinical response to quetiapine due t...

Pays Aucun
Organes Aucun
Spécialités Aucune

unknown

Plus d'informations